info@biomedres.us   +1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Review ArticleOpen Access

Clinical Manifestations in Intoxications by Tricyclic Antidepressants

Volume 8 - Issue 3

A Fernandez Ibanez*1, R Ugalde Herra2, JA Rodriguez Getino1, JB Garcia Casas1 and JC Diaz Suarez1

  • Author Information Open or Close
    • 1Department of Medicine, University of Oviedo, Spain
    • 2Hospital Universitario Central de Asturias, Oviedo, Spain

    *Corresponding author: A Fernandez Ibanez, Department of Medicine, University of Oviedo, Spain

Received: August 23, 2018;   Published: August 29, 2018

DOI: 10.26717/BJSTR.2018.08.001659

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Introduction: Tricyclic antidepressants are used in multiple psychiatric disorders such as depressive syndrome or attention deficit hyperactivity disorder. Acute intoxications by this drug if not treated in time, have a high mortality due to the cardiovascular effects that occur in the body.

Objective: Detect acute poisoning by tricyclic antidepressants with the analytical values in serum of patients who have symptoms compatible to establish treatment early.

Method: Review of the clinical history of patients who in the urine drug screening test were positive for tricyclic antidepressants and had a compatible electrocardiogram. Venous blood samples were processed in Cobas 6000 e501 (Roche Dignostics) by the homogeneous enzyme immunoassay technique.

Results: Differentiation in 3 groups of patients according to the plasma concentration values.

Conclusions: The quantification of the plasma concentration of tricyclic antidepressants offers additional information to confirm the diagnosis but not for the urgent treatment of these intoxicates because the free concentration of the drug is modified with pH or the individual variability.

It must remember that many of these intoxications are associated with benzodiazepine poisoning, so treatment with flumazenil is contraindicated because it can produce convulsions.

Abstract | Introduction | Patients and Methodology | Results | Discussion | Conclusion | References |